Literature DB >> 35068787

Surgical Procedures in Patients Awaiting Liver Transplantation: Complications and Impact on the Liver Function.

Imke Honerkamp1, Lisa Sandmann1, Nicolas Richter2, Michael P Manns1, Torsten Voigtländer1, Florian W R Vondran2, Thomas von Hahn1,3.   

Abstract

BACKGROUND: Potential indications for surgery frequently arise in patients awaiting liver transplantation. There is a risk of hepatic decompensation and death triggered by surgical trauma, but this has not been studied in detail in this unique population. We aimed to quantify the impact of surgical interventions in patients awaiting liver transplantation on hepatic function and identify risk factors for decompensation.
METHODS: All surgeries between 2000 and 2018 in patients awaiting liver transplantation in a highvolume German liver transplant center were analyzed retrospectively. Change in liver function measured as indicated by MELD score was assessed and complication rates recorded. The primary endpoint was a composite of an increase in MELD score by > 5 points or death. A logistic regression model was used for multivariate analysis to identify risk factors.
RESULTS: In total, 177 surgical procedures in 148 patients were analyzed. The primary endpoint was reached in 42 cases (23.7%). The overall in-hospital complication rate (including death) was 44.1%. Multivariate analysis identified elevated leukocyte count, perioperative blood transfusion, preoperative presence of ascites, and preoperative circulatory support as independent risk factors for a decline in liver function or death.
CONCLUSION: Surgery in patients awaiting liver transplantation carries a relevant risk of hepatic decompensation and death that needs to be considered when deciding whether to perform elective surgery prior to or defer until after liver transplantation.
© 2021 Indian National Association for Study of the Liver. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  ACLF, Acute-on-Chronic Liver Failure; ALT, Alanine transaminase; ASA, American Society of Anesthesiologists physical status classification system; AST, Aspartate transaminase; CHE, Cholinesterase; CRP, C-reactive Protein; HCC, Hepatocellular carcinoma; Hb, Hemoglobin; INR, International Normalized Ratio; MELD; MELD, Model for End-stage Liver Disease; OR, Odds Ratio; SBP, Spontaneous Bacterial Peritonitis; Tsd, Thousand; aPTT, Activated partial thromboplastin time; cirrhosis; dl, Deciliter; g, Gram; i.e., id est; l, Liter; liver transplantation; log, Logarithm; mg, Milligram; min, Minutes; mmol, Millimole; surgery; vs, Versus; waiting list; μl, Microliter

Year:  2021        PMID: 35068787      PMCID: PMC8766540          DOI: 10.1016/j.jceh.2021.03.011

Source DB:  PubMed          Journal:  J Clin Exp Hepatol        ISSN: 0973-6883


  34 in total

1.  Cardiac surgery in patients with liver cirrhosis: risk factors for predicting mortality.

Authors:  Cheng-Hsin Lin; Ron-Bin Hsu
Journal:  World J Gastroenterol       Date:  2014-09-21       Impact factor: 5.742

2.  The safety of intra-abdominal surgery in patients with cirrhosis: model for end-stage liver disease score is superior to Child-Turcotte-Pugh classification in predicting outcome.

Authors:  Alex S Befeler; Dean E Palmer; Martin Hoffman; Walter Longo; Harvey Solomon; Adrian M Di Bisceglie
Journal:  Arch Surg       Date:  2005-07

3.  Perioperative mortality after non-hepatic general surgery in patients with liver cirrhosis: an analysis of 138 operations in the 2000s using Child and MELD scores.

Authors:  Hannes Neeff; Dimitri Mariaskin; Hans-Christian Spangenberg; Ulrich T Hopt; Frank Makowiec
Journal:  J Gastrointest Surg       Date:  2011-01       Impact factor: 3.452

4.  Risk factors for nonhepatic surgery in patients with cirrhosis.

Authors:  Juan A del Olmo; Blas Flor-Lorente; Blas Flor-Civera; Felicidad Rodriguez; Miguel A Serra; Amparo Escudero; Salvador Lledó; José M Rodrigo
Journal:  World J Surg       Date:  2003-05-13       Impact factor: 3.352

5.  Open-heart surgery in patients with liver cirrhosis: indications, risk factors, and clinical outcomes.

Authors:  Y An; Y B Xiao; Q J Zhong
Journal:  Eur Surg Res       Date:  2007-02-01       Impact factor: 1.745

6.  Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis.

Authors:  Richard Moreau; Rajiv Jalan; Pere Gines; Marco Pavesi; Paolo Angeli; Juan Cordoba; Francois Durand; Thierry Gustot; Faouzi Saliba; Marco Domenicali; Alexander Gerbes; Julia Wendon; Carlo Alessandria; Wim Laleman; Stefan Zeuzem; Jonel Trebicka; Mauro Bernardi; Vicente Arroyo
Journal:  Gastroenterology       Date:  2013-03-06       Impact factor: 22.682

7.  Clinical outcomes of patients with liver cirrhosis who underwent curative surgery for gastric cancer: a retrospective multi-center study.

Authors:  Hyun Joo Jang; Jung Han Kim; Hun Ho Song; Kyung Hee Woo; Mi Kim; Sea Hyub Kae; Jin Lee; Ji Wong Cho; Jung Hun Kang; Soon Il Lee; Soo Jung Gong; Jung Ae Lee; Dae Young Zang
Journal:  Dig Dis Sci       Date:  2007-06-28       Impact factor: 3.199

8.  Predictors of mortality in patients on the waiting list for liver transplantation.

Authors:  Lívia Garcia Ferreira; Lucilene Rezende Anastácio; Agnaldo Soares Lima; Maria Isabel Touslon Davisson Correia
Journal:  Nutr Hosp       Date:  2013 May-Jun       Impact factor: 1.057

9.  Liver Cirrhosis/Severe Fibrosis Is a Risk Factor for Anastomotic Leakage after Colorectal Surgery.

Authors:  Samuel Andreas Käser; Irina Hofmann; Niels Willi; Felix Stickel; Christoph Andreas Maurer
Journal:  Gastroenterol Res Pract       Date:  2016-12-26       Impact factor: 2.260

10.  Prediction of nosocomial acute-on-chronic liver failure in patients with cirrhosis admitted to hospital with acute decompensation.

Authors:  Giacomo Zaccherini; Maurizio Baldassarre; Michele Bartoletti; Manuel Tufoni; Sonia Berardi; Mariarosa Tamè; Lucia Napoli; Antonio Siniscalchi; Angela Fabbri; Lorenzo Marconi; Agnese Antognoli; Giulia Iannone; Marco Domenicali; Pierluigi Viale; Franco Trevisani; Mauro Bernardi; Paolo Caraceni
Journal:  JHEP Rep       Date:  2019-08-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.